Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin for smoking cessation in patients with COPD
IRCT20190810044500N25Phase 3Completed
- Sponsor
- Shahid Sadoughi University of Medical Sciences
- Start
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of melatonin in nicotine dependence (2 arms), sponsored by Shahid Sadoughi University of Medical Sciences. Primary endpoints: Number of cigarettes consumed daily and Time of the first cigarette in the morning. Started Aug 2024; status: completed.
02
Drugs
melatonin
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on IRCT20190810044500N25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190810044500N25.